AMENDMENT #1 to License AgreementLicense Agreement • August 10th, 2016 • Spark Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Amendment #1 to License Agreement (the “First Amendment”) is entered into and made effective as of June 9, 2016 (the “First Amendment Effective Date”) and amends that certain License Agreement dated December 6, 2014 (the “License Agreement”), by and between Pfizer Inc., a corporation organized and existing under the laws of the State of Delaware with offices at 235 East 42nd Street, New York, New York 10017 (“Pfizer”) and Spark Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware with offices at 3737 Market Street, Suite 1300, Philadelphia, Pennsylvania 19104 (“Spark”). Pfizer and Spark are referred to herein individually as a “Party” and collectively as the “Parties”.
EMPLOYMENT AGREEMENTEmployment Agreement • August 10th, 2016 • Spark Therapeutics, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
This Employment Agreement (the “Agreement”) is made as of ____ ____, 2016, by and between Spark Therapeutics, Inc. (the “Company”), and ____, (the “Executive”) (together, the “Parties”).
